Pinto M - Search Results

1

Patients' costs and cost-effectiveness of tuberculosis treatment in DOTS and non-DOTS facilities in Rio de Janeiro, Brazil.

Steffen R, Menzies D, Oxlade O, Pinto M, de Castro AZ, Monteiro P, Trajman A. Steffen R, et al. Among authors: pinto m. PLoS One. 2010 Nov 17;5(11):e14014. doi: 10.1371/journal.pone.0014014. PLoS One. 2010. PMID: 21103344 Free PMC article.

2

[The cost of tobacco-related diseases for Brazil's Unified National Health System].

Pinto M, Ugá MA. Pinto M, et al. Cad Saude Publica. 2010 Jun;26(6):1234-45. doi: 10.1590/s0102-311x2010000600016. Cad Saude Publica. 2010. PMID: 20657987 Free article. Portuguese.

3

How methodologic differences affect results of economic analyses: a systematic review of interferon gamma release assays for the diagnosis of LTBI.

Oxlade O, Pinto M, Trajman A, Menzies D. Oxlade O, et al. Among authors: pinto m. PLoS One. 2013;8(3):e56044. doi: 10.1371/journal.pone.0056044. Epub 2013 Mar 7. PLoS One. 2013. PMID: 23505412 Free PMC article. Review.

4

Cost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil.

Steffen RE, Caetano R, Pinto M, Chaves D, Ferrari R, Bastos M, de Abreu ST, Menzies D, Trajman A. Steffen RE, et al. Among authors: pinto m. PLoS One. 2013 Apr 4;8(4):e59546. doi: 10.1371/journal.pone.0059546. Print 2013. PLoS One. 2013. PMID: 23593145 Free PMC article.

5

Patient costs for the diagnosis of tuberculosis in Brazil: comparison of Xpert MTB/RIF and smear microscopy.

da Silva Antunes R, Pinto M, Trajman A. da Silva Antunes R, et al. Among authors: pinto m. Int J Tuberc Lung Dis. 2014 May;18(5):547-51. doi: 10.5588/ijtld.13.0637. Int J Tuberc Lung Dis. 2014. PMID: 24903791

6

Market assessment of tuberculosis diagnostics in Brazil in 2012.

TB Diagnostics Market Analysis Consortium. TB Diagnostics Market Analysis Consortium. PLoS One. 2014 Aug 6;9(8):e104105. doi: 10.1371/journal.pone.0104105. eCollection 2014. PLoS One. 2014. PMID: 25099237 Free PMC article.

7

Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the Brazilian Unified Health Care System.

Pinto M, Entringer AP, Steffen R, Trajman A. Pinto M, et al. J Bras Pneumol. 2015 Nov-Dec;41(6):536-8. doi: 10.1590/S1806-37562015000004524. J Bras Pneumol. 2015. PMID: 26785963 Free PMC article.

8

Cost-effectiveness of the Xpert® MTB/RIF assay for tuberculosis diagnosis in Brazil.

Pinto M, Steffen RE, Cobelens F, van den Hof S, Entringer A, Trajman A. Pinto M, et al. Int J Tuberc Lung Dis. 2016 May;20(5):611-8. doi: 10.5588/ijtld.15.0455. Int J Tuberc Lung Dis. 2016. PMID: 27084814

9

[Contradictions and the cost-effectiveness threshold].

Santos MDS, Pinto M, Trajman A. Santos MDS, et al. Among authors: pinto m. Cad Saude Publica. 2017 Aug 21;33(8):e00096117. doi: 10.1590/0102-311X00096117. Cad Saude Publica. 2017. PMID: 28832782 Free article. Portuguese. No abstract available.

10

[Budget impact of the incorporation of GeneXpert MTB/RIF for diagnosis of pulmonary tuberculosis from the perspective of the Brazilian Unified National Health System, Brazil, 2013-2017].

Pinto MFT, Steffen R, Entringer A, Costa ACCD, Trajman A. Pinto MFT, et al. Cad Saude Publica. 2017 Oct 9;33(9):e00214515. doi: 10.1590/0102-311X00214515. Cad Saude Publica. 2017. PMID: 29019524 Free article. Portuguese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,943 results

Search Page